# BUPIVACAINE HYDROCHLORIDE
> **ANDA209087** · Abbreviated New Drug Application (Generic) · Sponsor: B BRAUN MEDICAL · Approved 2019-04-02
## Drug
- **FDA Application Number:** ANDA209087
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPIVACAINE HYDROCHLORIDE
- **Generic name:** BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE
- **Active ingredients:** BUPIVACAINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** SPINAL
- **Marketing status:** Prescription
- **Sponsor:** B BRAUN MEDICAL
- **Manufacturer:** B. Braun Medical Inc.
- **First approval:** 2019-04-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209087)
---
*MORVS · CC0 1.0*